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adults ineachjointcategory.Estimateswerestratifiedbysexand
age category. Analyses were conducted in Stata version 13.1
(StataCorp) using survey commands to account for the sam-
pling design, and full sample interviewweights were applied.
Results |Weanalyzeddata from5923adultswithcompletedata
(98.8% of total). Overall, 25.7% (95% CI, 23.0%-28.5%) re-
ported sitting for more than 8 hours per day and 44.6% (95%
CI, 40.2%-49.0%) were inactive. Across joint categories, the
greatest proportion of adults reported sitting for 6 to 8 hours
per day and being inactive (13.9%; 95% CI, 12.1%-16.0%), fol-
lowed by sitting for more than 8 hours per day and being in-
active (11.4%; 95% CI, 10.5%-12.4%), and sitting for 4 to less
than 6hours per day and being inactive (11.2%; 95%CI, 9.6%-
13.0%) (Figure). The smallest proportions reported sitting for
less than 4 hours per day and being sufficiently active (2.6%;
95%CI, 2.1%-3.2%) or sitting for less than4hours per day and
being insufficiently active (2.7%; 95% CI, 2.0%-3.6%). Pat-
ternswere similar by sex (Table). Somedifferences in the joint
distribution of sitting time and leisure-time physical activity
were observedbetween age categories. For example, the joint
prevalence of sitting formore than 8 hours per day and being
inactive increased with increasing age.
Discussion | These data reveal a substantial prevalence of high
sitting time and physical inactivity among US adults: about 1
in 4 sit for more than 8 hours a day, 4 in 10 are physically in-
active, and 1 in 10 report both. The limitations of this study in-
clude possible bias inherent in self-reported data and that
physical activity episodes shorter than 10 minutes may not
have been captured.
Bothhigh sedentarybehavior andphysical inactivityhave
negative health effects, and evidence suggests that the risk of
prematuremortality is particularly elevatedwhen they occur
together.1,2 Evidence-based strategies to reduce sitting time,
increase physical activity, or both would potentially benefit
mostUSadults,particularlyolderadults.Practitionerscansup-
port efforts to implement programs, practices, and policies
where adults live, learn, work, and play to help them sit less
and spendmore time being physically active.1,5,6
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COMMENT&RESPONSE
Validity of the qSOFA Score in Low- andMiddle-
Income Countries
To theEditorDrRuddandcolleagues1 concluded that thequick
Sequential (Sepsis-Related)OrganFailureAssessment (qSOFA)
scorewassuperior to thesystemic inflammatory responsesyn-
drome (SIRS) score and a baseline riskmodel in predicting in-
hospital mortality in low- and middle-income countries
(LMICs), an issue that has beendebated since its introduction
in the Sepsis-3 definitions.2,3We are concerned that the treat-
ment of missing data may have introduced significant bias.
More than half the data set was incomplete with respect
to human immunodeficiency virus or transfer status (compo-
nents of the baseline risk model) or white blood cell count (a
SIRScomponent).Theauthorsused thesame imputationstrat-
egy (substitution of clinically normal values) thatwas used in
theoriginal qSOFAderivation.3 Simple imputation schemesof
this kind are known to potentially yield biased estimates and
systematically underestimate uncertainty in estimated
parameters,4bothofwhichcan leadtowronglyconcluding that
one score is superior. The assumption of clinical normality
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couldbias downward thepredictive ability of thebaseline risk
and SIRS models, inflating the apparent additive discrimina-
tory ability of the qSOFAmodel. The evidence for superiority
of qSOFA largely disappeared in the sensitivity analyseswhen
excluding these missing variables or using a more sophisti-
cated imputation strategy.5
When comparing theperformanceof themany scores that
predictmortality, qSOFAandothers share the samedeficiency
with respect to medical practice in LMICs: they provide nei-
ther a basis for specifically directing clinical management nor
a foundation for research into improving care. If they are to be
useful in practice, strategies to link mortality identification
scores to clinical action in LMICs are needed. We suggest that
the incremental benefit of disease-specific scores should be
weighed against the fragmentation of care for critically unwell
patients. The opportunity costs of deploying a scoring system
are significant, and especially so where resources are limited.
Outcomes in critical illness are poor but might be better ad-
dressedbyamorebroadlyapplicablebut lessdiscriminantscore,
tied to careful assessment of implementation.
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In Reply We agree with Dr Lewis and colleagues that missing
data can be an important limitation in clinical research, in-
cluding our analysis of the predictive validity of the qSOFA
score and SIRS criteria.1 There are 2 issues related to missing
data: (1) whymissing data are present and (2) the approach to
missing data during analysis. First, missing data were pre-
sent in all 9 cohorts included in the study. Many sites lacked
electronic health record systems, had limited medical staff
available to collect and record serial vital signs, andwere un-
able to routinely perform laboratory testing for every patient
with suspected infection because of limited laboratory and
financial resources. Given this reality, the diagnosis of sepsis
inLMICswill not alwaysbe informedbycompletedata. There-
fore, it is useful for clinicians in low-resource settings to un-
derstandtheperformanceofalternativescoringsystems insitu-
ations in which some variables, though important predictors
of clinical outcome, may be missing.
Second, therearemultiplestatisticalmethodsfor theanaly-
sis ofmissingdata, all ofwhichmay introduce bias. In our pri-
maryanalysis,weusedsinglenormalvalue imputation,which
is standard in clinical risk scores2-4 and most closely re-
sembleshowclinicianswoulduse the score at thebedside.We
agree with Lewis and colleagues that this approach can bias
downward the predictive ability ofmodelswithmissing data,
but point out that there were missing data among the qSOFA
score components as well as the baseline risk and SIRS mod-
els. Given concerns for possible bias with this statistical
method, we performedmany sensitivity analyses focused on
the issue ofmissing data (eTable 7 in the Supplement1).While
the magnitude of effect sometimes changed in these analy-
ses, all the findings were in the same direction and remained
statistically significant.
We believe that the most important way to mitigate the
challenges of missing data in some LMIC settings is to ad-
dress the challenges of poverty and health inequity that lead
tomissing clinical data in the first place,whichwill require ad-
equate financial support to fund the health care systems and
clinicians thatareprovidingcare to thesepatients.Greaterclini-
cal research infrastructure with distributive data networks
could also ensure data quality and availability.
Lewis and colleagues raise the broader issue of the utility
of the qSOFA score relative to other general risk scores. The
qSOFAscorewasnotdesignedasamortalitypredictiontool,but
ratheroneto identifypatientswiththehighest likelihoodofsep-
sis. As such, predictive validity, the foundational approach of
the study, is an assessment of how well the qSOFA score per-
formed in terms of selecting patients who may later develop
downstreamevents associatedwith sepsis. In this case, hospi-
talmortalitywasusedas thedownstreameventassociatedwith
sepsis (as sepsis is by definition life-threatening), but it is only
oneexampleof several possible endpoints.Oncepatientswith
sepsis are identified, we agree that strategies for optimal sep-
sis management in LMIC settingsmust be better developed.
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couldbias downward thepredictive ability of thebaseline risk
and SIRS models, inflating the apparent additive discrimina-
tory ability of the qSOFAmodel. The evidence for superiority
of qSOFA largely disappeared in the sensitivity analyseswhen
excluding these missing variables or using a more sophisti-
cated imputation strategy.5
When comparing theperformanceof themany scores that
predictmortality, qSOFAandothers share the samedeficiency
with respect to medical practice in LMICs: they provide nei-
ther a basis for specifically directing clinical management nor
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useful in practice, strategies to link mortality identification
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Maryland’s Hospital Global Budget Program
To the Editor In a Viewpoint, Dr Sharfstein and colleagues as-
sessed thestateof evidenceonMaryland’shospital globalbud-
get program.1 We agree with much of their synthesis, includ-
ing that hospital admissions declined in Maryland following
theprogram’s implementation, butwe arenot convinced that
these changes can be attributed to global budgets.
Because admissions also decreased in other states, it is im-
portant to select an appropriate control population to isolate
changesassociatedwithhospital global budgets.1 The standard
assumption is that differences between intervention and con-
trol populations would have remained constant without
Maryland’s policy and, therefore, any differential change from
thepreintervention to thepostinterventionperiodcanbe inter-
preted as a policy effect. Evidence of parallel preintervention
trendssupportsthisassumptionbutdoesnotguaranteeitholds.2
In 2 recent studies of Maryland’s program, the standard
assumptionwasnot supportedbecausepreintervention trends
differedonmostoutcomes.3,4 Inboth studies, researchers rec-
ognized this problem and made the assumption that, absent
the intervention, differences in preintervention trends be-
tweenMaryland and the control populationwould have con-
tinued into the postintervention period. Although reason-
able, this assumption may be violated because differential
trends are unlikely to continue indefinitely.
In the studybyRoberts et al,3 this seeminglyminormeth-
odological issuewas critically important. Under one assump-
tion, Maryland’s program may have been associated with
changes in admissions, but the conclusion differed under the
other assumption.Other issues, suchashowtoaddress the in-
creasing use of hospital observation stays, were also impor-
tant in evaluating the program.
In situations inwhichmethodological choicesmay affect
the conclusion, it is important to conduct sensitivity analy-
ses and toassess the totalityof evidence.Thesensitivity analy-
ses in the study by Roberts et al3 suggested that the differen-
tial reduction in admissions in Maryland was not uniquely
large, and results from a separate study of Maryland’s pilot
introduction of global budgets in rural hospitals (where
treatment and control groups had similar trends before
introduction)5 found no change in hospital utilization due to
global budgets.
Based on the totality of evidence, we believe caution is
needed in ascribing early changes in utilization to global bud-
gets in Maryland. The inability of researchers to confidently
identifyearlyeffectsofMaryland’sprogramdoesnot imply that
this policy failed, nor does it preclude the potential for ef-
fects to emerge over time. Continued evaluation and efforts
to strengthen Maryland’s model, as Sharfstein and col-
leagues advocated,1 remain vital next steps.
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In Reply Dr Roberts and colleagues are “not convinced” that
Maryland’s unique approach to paying hospitals was respon-
sible for changes in care and cost in the state.1 We cited the
studies by Roberts and colleagues because they contributed
to understanding this question. We also cited other research,
including analyses with a similar methodology but with
a greater quantity of more recent data that did find signifi-
cant associations.2
Statewide models of health care reform are difficult to
evaluate. Not only are there issues with assumptions, as
Roberts and colleagues note, but the results are quite depen-
dent on the choice of a comparison group. Thus, a variety of
methods for understanding state reform are needed, includ-
ing both qualitative and quantitative assessments. Investiga-
tors should be cautious about asserting that a single ap-
proach or study holds the answer to key questions.
Marylandhas fundamentally changed financial incentives
forhospitals,andthesechangesmayhave importanteffects,po-
tentially both good and bad, on the provision of care and on
populationhealth.Researchersandpolicymakers shouldwork
together to learn from the state’s ambitious efforts.
Joshua M. Sharfstein, MD
Elizabeth A. Stuart, PhD
Joseph Antos, PhD
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